# Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy

> **NCT07122466** · — · ACTIVE_NOT_RECRUITING · sponsor: **Northwell Health** · enrollment: 24 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Tumor DNA circulating in the bloodstream (circulating tumor DNA; ctDNA)

## Key facts

- **NCT ID:** NCT07122466
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-22
- **Primary completion:** 2023-10-17
- **Final completion:** 2025-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122466, "Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07122466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*